Alicia Pierse
Hospitalist · Baytown, TXNPI 1881345452
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $989 and has fallen 98.2% since, to $17 in 2025. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$281
- Daiichi Sankyo Inc.$124
- Novartis$121
- Stemline Therapeutics Inc.$120
- Bristol Myers Squibb$103
- Sobi, Inc$103
- plus $841 from 19 others
What the payments were for
- Food & beverage$1,60895%
- Education$855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $281 |
| Daiichi Sankyo Inc. | 6 | $124 |
| Novartis | 6 | $121 |
| Stemline Therapeutics Inc. | 1 | $120 |
| Bristol Myers Squibb | 5 | $103 |
| Sobi, Inc | 2 | $103 |
| Amgen | 5 | $100 |
| CTI Biopharma Corp. | 4 | $89 |
| AVEO Pharmaceuticals, Inc. | 3 | $82 |
| GSK | 3 | $82 |
| Merck | 3 | $74 |
| Tersera Therapeutics LLC | 2 | $53 |
| Pharmaessentia USA Corporation | 2 | $50 |
| Taiho Oncology, Inc. | 3 | $46 |
| Shield Therapeutics Inc | 2 | $41 |
| Eisai Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Apellis Pharmaceuticals, Inc. | 1 | $27 |
| Morphosys, US Inc. | 1 | $21 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Spectrum Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orserdu$120
How this compares
$1,693 in reported general payments places this provider in the 90th percentile of 1,284 hospitalist providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,012 |
| Doxycycline Hyclate | 22 | $103 |
| Methylprednisolone | 13 | $69 |
| Atorvastatin Calcium | 11 | $58 |
| Amlodipine Besylate | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Baytown
- Rody Bou ChaayaBaytown$6K
- Daniel NguyenBaytown$4K
- Maricel JumawanBaytown$3K
- Kenechukwu EnekebeCorpus Christi$311K
- Ryan NealHouston$154K
- Sarah SmileyAustin$90K
- Mubeen CheemaSan Antonio$50K
- Ahmad BaroutHouston$44K
- Tarek HammadSan Antonio$42K
- Hendre FichardtSan Antonio$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.